U.S. Pharmaceuticals & Biotech Mid-Large Cap Stocks

Bruker

Market Cap: US$5.6b

Develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally.

Apogee Therapeutics

Market Cap: US$2.3b

A clinical stage biotechnology company, develops novel biologics for the treatment of atopic dermatitis (AD), asthma, eosinophilic esophagitis (EoE), chronic obstructive pulmonary disease (COPD), and other inflammatory and immunology indications.

Jazz Pharmaceuticals

Market Cap: US$6.6b

Jazz Pharmaceuticals plc identifies, develops, and commercializes pharmaceutical products in the United States, Europe, and internationally.

Supernus Pharmaceuticals

Market Cap: US$1.8b

A biopharmaceutical company, develops and commercializes products for the treatment of central nervous system (CNS) diseases in the United States.

Insmed

Market Cap: US$12.0b

Develops and commercializes therapies for patients with serious and rare diseases in the United States, Europe, Japan, and internationally.

Vera Therapeutics

Market Cap: US$1.4b

A clinical stage biotechnology company, focuses on the development and commercialization of transformative treatments for patients with serious immunological diseases.

NewAmsterdam Pharma

Market Cap: US$2.1b

A late-stage biopharmaceutical company, develops therapies to enhance patient care in populations with metabolic disease.

Elanco Animal Health

Market Cap: US$6.4b

An animal health company, innovates, develops, manufactures, and markets products for pets and farm animals worldwide.

Xenon Pharmaceuticals

Market Cap: US$2.3b

A neuroscience-focused biopharmaceutical company, engages in the discovery, development, and delivery of therapeutics to treat patients with neurological and psychiatric disorders in Canada.

Innoviva

Market Cap: US$1.1b

Engages in the development and commercialization of pharmaceutical products in the United States and internationally.

BioCryst Pharmaceuticals

Market Cap: US$2.1b

A biotechnology company, develops oral small-molecule and injectable protein therapeutics to treat rare diseases.

Neurocrine Biosciences

Market Cap: US$11.8b

Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, neuroendocrine, and neuropsychiatric disorders in the United States and internationally.

Roivant Sciences

Market Cap: US$7.6b

A commercial-stage biopharmaceutical company, engages in the development and commercialization of medicines for inflammation and immunology areas.

Janux Therapeutics

Market Cap: US$1.3b

A clinical stage biopharmaceutical company, develops immunotherapies based on Tumor Activated T Cell Engager (TRACTr) and Tumor Activated Immunomodulator (TRACIr) platforms technology to treat patients with cancer.

Vericel

Market Cap: US$2.1b

A commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies and specialty biologic products for sports medicine and severe burn care markets in North America.

Repligen

Market Cap: US$7.2b

A life sciences company, develops and commercializes bioprocessing technologies and systems in North America, Europe, the Asia Pacific, and internationally.

Krystal Biotech

Market Cap: US$3.8b

A commercial-stage biotechnology company, discovers, develops, manufactures, and commercializes genetic medicines to treat diseases with high unmet medical needs in the United States.

Rhythm Pharmaceuticals

Market Cap: US$3.6b

A commercial-stage biopharmaceutical company, focuses on the rare neuroendocrine diseases.

Prestige Consumer Healthcare

Market Cap: US$4.2b

Develops, manufactures, markets, distributes, and sells over the counter (OTC) health and personal care products in North America, Australia, and internationally.

Revvity

Market Cap: US$10.7b

Provides health sciences solutions, technologies, and services worldwide.

Denali Therapeutics

Market Cap: US$2.0b

A biopharmaceutical company, discovers and develops therapeutics to treat neurodegenerative and lysosomal storage diseases.

IQVIA Holdings

Market Cap: US$24.5b

Provides clinical research services, commercial insights, and healthcare intelligence to the life sciences and healthcare industries in the Americas, Europe, Africa, and the Asia-Pacific.

BridgeBio Pharma

Market Cap: US$6.4b

A commercial-stage biopharmaceutical company, discovers, creates, tests, and delivers transformative medicines to treat patients who suffer from genetic diseases and cancers.

Celldex Therapeutics

Market Cap: US$1.3b

A biopharmaceutical company, engages in developing therapeutic antibodies for patients with severe inflammatory, allergic, autoimmune, and other diseases.

Ligand Pharmaceuticals

Market Cap: US$2.0b

A biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide.

ANI Pharmaceuticals

Market Cap: US$1.2b

A biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally.

Liquidia

Market Cap: US$1.6b

A biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States.

BeiGene

Market Cap: US$23.8b

An oncology company, engages in discovering and developing various treatments for cancer patients in the United States, China, Europe, and internationally.

Bio-Rad Laboratories

Market Cap: US$6.5b

Manufactures and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America.

Summit Therapeutics

Market Cap: US$16.9b

A biopharmaceutical company, focuses on discovery, development, and commercialization of patient, physician, caregiver, and societal friendly medicinal therapies.

Harmony Biosciences Holdings

Market Cap: US$1.9b

A commercial-stage pharmaceutical company, focuses on developing and commercializing therapies for patients with rare and other neurological diseases in the United States.

Vertex Pharmaceuticals

Market Cap: US$108.2b

A biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis (CF).

Teva Pharmaceutical Industries

Market Cap: US$19.4b

Develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel, and internationally.

Viking Therapeutics

Market Cap: US$3.0b

A clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders.

Cytokinetics

Market Cap: US$3.6b

A late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases in the United States.

ICON

Market Cap: US$10.5b

A clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally.